The expanding universe of p53 targets

Menendez, Daniel, Inga, Alberto, Resnick, Michael A.·2009·Nature Reviews Cancer

DOI 10.1038/nrc2730

Cited by (567)

Items 101–200 of 567

Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells
Jing Zhao, Yixin Lü, Han‐Ming Shen · 2011 · Cancer Letters
The nucleolus, an ally, and an enemy of cancer cells
Dariusz Stępiński · 2018 · Histochemistry and Cell Biology
The p53/microRNA Network in Cancer: Experimental and Bioinformatics Approaches
Sabine Hünten, Helge Siemens, Markus Kaller, Heiko Hermeking · 2012 · Advances in experimental medicine and biology
p53’s Extended Reach: The Mutant p53 Secretome
Evangelos Pavlakis, Thorsten Stiewe · 2020 · Biomolecules
Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53
Ido Goldstein, Noa Rivlin, Or-yam Shoshana, Osnat Ezra, Shalom Madar, Naomi Goldfinger, Varda Rotter · 2012 · Carcinogenesis
Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?
Ignacio Campillo‐Marcos, Pedro A. Lazo · 2018 · Cellular and Molecular Life Sciences
PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context
Teresa Valentino, Dario Palmieri, Michela Vitiello, Giovanna Maria Pierantoni, Alfredo Fusco, Monica Fedele · 2013 · Cell Death and Disease
p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB
Quan Zhang, Liye Cao, Shujie Cheng, Aimin Zhang, Xiaoshi Jin, Yong Li · 2015 · Oncology Reports
Haploinsufficient tumor suppressor genes.
Kazushi Inoue, Elizabeth A. Fry · 2017 · PubMed
Structural and Drug Targeting Insights on Mutant p53
Ana Sara Gomes, Helena Ramos, Alberto Inga, Emı́lia Sousa, Lucı́lia Saraiva · 2021 · Cancers
More targets, more pathways and more clues for mutant p53
Sonia Garritano, Alberto Inga, Federica Gemignani, Stefano Landi · 2013 · Oncogenesis
p53 integrates host defense and cell fate during bacterial pneumonia
Jennifer H. Madenspacher, Kathleen M. Azzam, Kymberly M. Gowdy, Kenneth C. Malcolm, Jerry A. Nick, Darlene Dixon, Jim J. Aloor, David W. Draper, John J. Guardiola, Maria Shatz et al. · 2013 · The Journal of Experimental Medicine
CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress
Fekry, Baharan, Jeffries, Kristen A., Esmaeilniakooshkghazi, Amin, Ogretmen, Besim, Krupenko, Sergey A., Krupenko, Natalia I. · 2016 · Journal of Biological Chemistry
The roles of viruses in brain tumor initiation and oncomodulation
Alexander V. Kofman, Lucasz Marcinkiewicz, Evan Dupart, Anton Lyshchev, Мартынов Борис Владимирович, Anatolii Ryndin, Elena Kotelevskaya, Jay Brown, David Schiff, Roger Abounader · 2011 · Journal of Neuro-Oncology
Allosteric modulation of protein oligomerization: an emerging approach to drug design
Ronen Gabizon, Assaf Friedler · 2014 · Frontiers in Chemistry
Phenotype Specific Analyses Reveal Distinct Regulatory Mechanism for Chronically Activated p53
Kristina Kirschner, Shamith Samarajiwa, Jonathan Cairns, Suraj Menon, Pedro Antonio Pérez-Mancera, Kosuke Tomimatsu, Camino Bermejo‐Rodríguez, Yoko Ito, Tamir Chandra, Masako Narita et al. · 2015 · PLoS Genetics
Generation of a reference transcriptome for evaluating rainbow trout responses to various stressors
Cecilia Castaño-Sánchez, Gregory M. Weber, Guangtu Gao, Beth M. Cleveland, Jianbo Yao, Caird E. Rexroad · 2011 · BMC Genomics
Alterations of p63 and p73 in Human Cancers
Kazushi Inoue, Elizabeth A. Fry · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
The dual role of p53: DNA protection and antioxidant
Consuelo Borrás, Mari Carmen Gómez‐Cabrera, José Viña · 2011 · Free Radical Research
SPATA18, a Spermatogenesis-Associated Gene, Is a Novel Transcriptional Target of p53 and p63
Chamutal Bornstein, Ran Brosh, Alina Molchadsky, Shalom Madar, Ira Kogan-Sakin, Ido Goldstein, Deepavali Chakravarti, Elsa Renee Flores, Naomi Goldfinger, Rachel Sarig et al. · 2011 · Molecular and Cellular Biology
Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin
Tania Velletri, Yin Huang, Yu Wang, Qing Li, Mingyuan Hu, Ningxia Xie, Qian Yang, Qing Chen, Qing Chen, Peishun Shou et al. · 2020 · Cell Death and Differentiation
Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.
Nilank C Shah, Gatha J Shah, Zhiqiang Li, Xian‐Cheng Jiang, Bella T. Altura, Burton M. Altura · 2014 · Europe PMC (PubMed Central)
One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Levin Böhlig, Karen Rother · 2011 · BioMed Research International
Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance
Jad I. Belle, Jessica C. Petrov, David Langlais, François Robert, Regina Cencic, Shiyang Shen, Jerry Pelletier, Philippe Gros, Anastasia Nijnik · 2016 · Cell Death and Differentiation
Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
Tiffany DeVine, Mu‐Shui Dai · 2013 · Current Pharmaceutical Design
Mechanisms associated with mitochondrial-generated reactive oxygen species in cancerThis article is one of a selection of papers published in a Special Issue on Oxidative Stress in Health and Disease.
Meghan L. Verschoor, Amy‐Leigh Wilson, Gurmit Singh · 2010 · Canadian Journal of Physiology and Pharmacology
To repress or not to repress: This is the guardian's question
John L. Rinn, Maite Huarte · 2011 · Trends in Cell Biology
Gain of function of mutant p53: R282W on the peak?
Yao Zhang, Samya Van Coillie, J-Y Fang, Jie Xu · 2016 · Oncogenesis
Identification of new p53 target microRNAs by bioinformatics and functional analysis
Alessandra Bisio, Veronica De Sanctis, Valerio Del Vescovo, Michela A. Denti, Anil Goud Jegga, Alberto Inga, Yari Ciribilli · 2013 · BMC Cancer
Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2
Jing Zhang, Shu Kan, Bryant Huang, Zhenyue Hao, Tak W. Mak, Qing Zhong · 2011 · Genes & Development
Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
Naoe Taira, Kiyotsugu Yoshida · 2012 · PubMed
MicroRNAs, wild-type and mutant p53: More questions than answers
Matthew F. Jones, Ashish Lal · 2012 · RNA Biology
Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene
Dan Vodo, Ofer Sarig, Shamir Geller, Edna Ben‐Asher, Tsviya Olender, Ron Bochner, Ilan Goldberg, Judith S Nosgorodsky, Anna Alkelai, Pavel Tatarskyy et al. · 2016 · PLoS Genetics
Microscopy-based high-throughput assays enable multi-parametric analysis to assess adverse effects of nanomaterials in various cell lines
Iris Hansjosten, Juliane Rapp, Luisa Reiner, Ruben Vatter, Susanne Fritsch‐Decker, Ravindra Peravali, Taina Palosaari, Elisabeth Joossens, Kirsten Gerloff, Peter Macko et al. · 2017 · Archives of Toxicology
Effects on DNA Damage and/or Repair Processes as Biological Mechanisms Linking Psychological Stress to Cancer Risk
Frank J. Jenkins, Bennett Van Houten, Dana Howard Bovbjerg · 2014 · Journal of Applied Biobehavioral Research
Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets
Itai Beno, Karin Rosenthal, Michael Levitine, Lihi Shaulov, Tali E. Haran · 2010 · Nucleic Acids Research
Protein-Protein Interactions: Principles, Techniques, and their Potential Role in New Drug Development
Shagufta H. Khan, Faizan Ahmad, Nihal Ahmad, Daniel C. Flynn, Raj Kumar · 2011 · Journal of Biomolecular Structure and Dynamics
Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1a
Baofeng Wang, Xi-Jing Wang, Huafeng Kang, Minghua Bai, Haitao Guan, Zhong-Wei Wang, Ying Zan, Lingqin Song, Weili Min, Shuai Lin et al. · 2014 · Cellular Physiology and Biochemistry
VRK1 interacts with p53 forming a basal complex that is activated by UV‐induced DNA damage
Inmaculada López-Sánchez, Alberto Valbuena, Marta Vázquez-Cedeira, Jyoti Khadake, Marta Sanz-García, Alejandro Carrillo-Jiménez, Pedro A. Lazo · 2014 · FEBS Letters
Structure of p73 DNA-binding domain tetramer modulates p73 transactivation
Abdul Samath Ethayathulla, Pui Wah Tse, Paola Monti, Sonha Nguyen, Alberto Inga, Gilberto Fronza, Héctor Viadiu · 2012 · Proceedings of the National Academy of Sciences
SIRT2‐mediated inactivation of p73 is required for glioblastoma tumorigenicity
Kosuke Funato, Tomoatsu Hayashi, Kanae Echizen, Lumi Negishi, Naomi Shimizu, Ryo Koyama‐Nasu, Yukiko Nasu‐Nishimura, Yasuyuki Morishita, Viviane S. Tabar, Tomoki Todo et al. · 2018 · EMBO Reports
The signaling pathways regulated by KRAB zinc-finger proteins in cancer
Mengying Sun, Jiyu Ju, Yue Ding, Chunling Zhao, Chunyan Tian · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation
Yoav Shetzer, Alina Molchadsky, Varda Rotter · 2016 · Cold Spring Harbor Perspectives in Medicine
p53 directly activatescystatin D/CST5to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3
Sabine Hünten, Heiko Hermeking · 2015 · Oncotarget
Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
Marsha Pellegrino, Francesca Mancini, Rossella Lucà, Alice Coletti, Nicola Giacchè, Isabella Manni, Ivan Arisi, Fulvio Florenzano, Emanuela Teveroni, Marianna Buttarelli et al. · 2015 · Cancer Research
Mapping the p53 transcriptome universe using p53 natural polymorphs
Bei Wang, D Niu, Tze Hau Lam, Ziwei Xiao, Ee Chee Ren · 2013 · Cell Death and Differentiation
The Rich World of p53 DNA Binding Targets: The Role of DNA Structure
Václav Brázda, Miroslav Fojta · 2019 · International Journal of Molecular Sciences
p53: Pro-aging or pro-longevity?
de Keizer, Peter L.J., Laberge, Rémi-Martin, Campisi, Judith · 2010 · Aging
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences
Daniel Menéndez, Alberto Inga, Michael A. Resnick · 2010 · Proceedings of the National Academy of Sciences
Involvement of stromal p53 in tumor-stroma interactions
Jair Bar, Neta Ben-Chaim Moskovits, Moshe Oren · 2009 · Seminars in Cell and Developmental Biology
Inhibition of p53 after acute myocardial infarction: Reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture
Ying Zhang, Katharina Köhler, Jia Xu, Di Lu, Thomas W Braun, Axel Schlitt, Michael Buerke, Ursula Müller‐Werdan, Karl Werdan, Henning Ebelt · 2010 · Journal of Molecular and Cellular Cardiology
PHD1 regulates p53‐mediated colorectal cancer chemoresistance
Sofie Deschoemaeker, Giusy Di Conza, Sérgio Lilla, Rosa Martín‐Pérez, Daniela Mennerich, Lise Boon, Stefanie Hendrikx, Oliver D.K. Maddocks, Christian Marx, Praveen Radhakrishnan et al. · 2015 · EMBO Molecular Medicine
p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo
Sydney M. Moyer, Amanda R. Wasylishen, Yuan Qi, Natalie Wall Fowlkes, Xiaoping Su, Guillermina Lozano · 2020 · Proceedings of the National Academy of Sciences
Role and interaction of p53, BAX and the stress-activated protein kinases p38 and JNK in benzo(a)pyrene-diolepoxide induced apoptosis in human colon carcinoma cells
Julia Donauer, Ilona Schreck, Urban Liebel, Carsten Weiß · 2011 · Archives of Toxicology
Vpr-Binding Protein Antagonizes p53-Mediated Transcription via Direct Interaction with H3 Tail
Kyunghwan Kim, Kyu Heo, Jongkyu Choi, Sarah Jackson, Hyun‐Jung Kim, Yue Xiong, Woojin An · 2011 · Molecular and Cellular Biology
New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
Gang Guo, Yan Ru Cui · 2015 · Journal for ImmunoTherapy of Cancer
Differentiation of human placental BeWo cells by the environmental contaminant benzo(a)pyrene
Marc Le Vée, Élise Kolasa, Elodie Jouan, Nicolas Collet, Olivier Fardel · 2013 · Chemico-Biological Interactions
MicroRNA Cancer Regulation
Ulf Schmitz, Olaf Wolkenhauer, Julio Vera · 2013 · Advances in experimental medicine and biology
New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins
Dmitrij Golovenko, Bastian Bräuning, Pratik Vyas, Tali E. Haran, H. Rozenberg, Zippora Shakked · 2018 · Structure
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities
Sangeeta Kumari, Vikas Sharma, Rahul Tiwari, Jay Prakash Maurya, Bharat Bhusan Subudhi, Dhirodatta Senapati · 2022 · European Journal of Pharmacology
TP53 Mutants in the Tower of Babel of Cancer Progression
Alessandra Bisio, Yari Ciribilli, Gilberto Fronza, Alberto Inga, Paola Monti · 2014 · Human Mutation
Diverse p53/DNA binding modes expand the repertoire of p53 response elements
Pratik Vyas, Itai Beno, Zhiqun Xi, Yan Stein, Dmitrij Golovenko, Naama Kessler, Varda Rotter, Zippora Shakked, Tali E. Haran · 2017 · Proceedings of the National Academy of Sciences
Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
Pankaj Taneja, Sinan Zhu, Dejan Maglic, Eizabeth A. Fry, Robert D. Kendig, Kazushi Inoue · 2011 · Clinical Medicine Insights Oncology
p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
Lindi Chen, Deborah A. Tweddle · 2012 · Frontiers in Oncology
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
Yari Ciribilli, Paola Monti, Alessandra Bisio, H. Thien Nguyen, Abdul Samath Ethayathulla, A. Ramos, Giorgia Foggetti, Paola Menichini, Daniel Menéndez, Michael A. Resnick et al. · 2013 · Nucleic Acids Research
Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway
Mai Nagasaka, Ryoko Hashimoto, Yasumichi Inoue, Kan’ichiro Ishiuchi, Michiyo Matsuno, Yuka Itoh, Muneshige Tokugawa, Nobumichi Ohoka, Daisuke Morishita, Hajime Mizukami et al. · 2018 · Molecules
Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells
Séverine Cruet-Hennequart, Áine M. Prendergast, Georgina Shaw, Frank Barry, Michael P. Carty · 2012 · International Journal of Hematology
Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis
Y-C Chen, James Yi‐Hsin Chan, Y-L Chiu, S. T. Liu, Guillermina Lozano, S. -L. Wang, C-L Ho, S-M Huang · 2013 · Cell Death and Differentiation
Epirubicin Upregulates UDP Glucuronosyltransferase 2B7 Expression in Liver Cancer Cells via the p53 Pathway
Dong Gui Hu, Anne Rogers, Peter I. Mackenzie · 2014 · Molecular Pharmacology
Proteome Stability as a Key Factor of Genome Integrity
Sentiljana Gumeni, Zoi Evangelakou, Vassilis G. Gorgoulis, Ioannis P. Trougakos · 2017 · International Journal of Molecular Sciences
Regulation of Signal Transduction by DJ-1
Stephanie E. Oh, M. Maral Mouradian · 2017 · Advances in experimental medicine and biology
Filling gaps in translesion DNA synthesis in human cells
Annabel Quinet, Letícia Koch Lerner, Davi Jardim Martins, Carlos Frederico Martins Menck · 2018 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises breast cancer cells MCF7 to staurosporine and camptothecin-induced cell death
Pontsho Moela, Mpho Susan Choene, Lesetja Raymond Motadi · 2014 · Immunobiology
p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
Virginia Andreotti, Yari Ciribilli, Paola Monti, Alessandra Bisio, Mattia Lion, Jennifer Jordan, Gilberto Fronza, Paola Menichini, Michael A. Resnick, Alberto Inga · 2011 · PLoS ONE
Alkaline ceramidase 2 is a novel direct target of p53 and induces autophagy and apoptosis through ROS generation
Yitao Wang, Chunxue Zhang, Yuelei Jin, Wang, Qing He, Zhu Liu, Qing Ai, Yunlong Lei, Yi Li, Fangzhou Song et al. · 2017 · Scientific Reports
Awakening the “guardian of genome”: reactivation of mutant p53
Akshay Binayke, Sarthak Mishra, Prabhat Suman, Suman Das, Harish Chander · 2018 · Cancer Chemotherapy and Pharmacology
Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma
Bin Yan, Huai Li, Xinping Yang, Jiaofang Shao, Minyoung Jang, Daogang Guan, Sige Zou, Carter Van Waes, Zhong Chen, Ming Zhan · 2013 · PLoS ONE
Aberrant splicing of the DMP1 ‐ ARF ‐ MDM2 ‐p53 pathway in cancer
Kazushi Inoue, Elizabeth A. Fry · 2016 · International Journal of Cancer
The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53
Daniel Menéndez, Thuy‐Ai Nguyen, Joyce R. Snipe, Michael A. Resnick · 2017 · Molecular Cancer Research
Early Passage Mesenchymal Stem Cells Display Decreased Radiosensitivity and Increased DNA Repair Activity
Po‐Kuei Wu, Jir‐You Wang, Cheng‐Fong Chen, Kuang-Yu Chao, Ming-Chau Chang, Wei‐Ming Chen, Shih‐Chieh Hung · 2017 · Stem Cells Translational Medicine
Role of p53 in Regulating Radiation Responses
Ryuji Okazaki · 2022 · Life
p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
Yaxue Zeng, Yojiro Kotake, Xin‐Hai Pei, Matthew D. Smith, Yue Xiong · 2011 · Cancer Research
Dmp1 Physically Interacts with p53 and Positively Regulates p53′s Stability, Nuclear Localization, and Function
Donna P. Frazier, Robert D. Kendig, Fumitake Kai, Dejan Maglic, Takayuki Sugiyama, Rachel L. Morgan, Elizabeth A. Fry, Sarah J. Lagedrost, Guangchao Sui, Kazushi Inoue · 2012 · Cancer Research
Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ
Zackie Aktary, Stephen C. Kulak, John Robert Mackey, Nadia Jahroudi, Manijeh Pasdar · 2013 · Journal of Cell Science
Development of anticancer drugs based on the hallmarks of tumor cells
Natalia Bailón-Moscoso, Juan Carlos Romero-Benavides, Patricia Ostrosky‐Wegman · 2014 · Tumor Biology
High prevalence of acquired cancer-related mutations in 146 human pluripotent stem cell lines and their differentiated derivatives
Elyad Lezmi, Jonathan Jung, Nissim Benvenisty · 2024 · Nature Biotechnology
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics
Mattia Lion, Alessandra Bisio, Toma Tebaldi, Veronica De Sanctis, Daniel Menéndez, Michael A. Resnick, Yari Ciribilli, Alberto Inga · 2013 · Cell Cycle
The NF-Y/p53 liaison: Well beyond repression
Carol Imbriano, Nerina Gnesutta, Roberto Mantovani · 2011 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63
Yannick von Grabowiecki, Paula Abreu, Orphée Blanchard, Lavinia Palamiuc, Samir Benosman, Sophie B. Mériaux, Véronique Devignot, Isabelle Groß, Georg Mellitzer, José‐Luis González de Aguilar et al. · 2016 · eLife
Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer
Yangzom Doma Bhutia, Jiro Ogura, Paul J. Grippo, Carolina Torres, Toshihiro Sato, Mitchell Steven Wachtel, Sabarish Ramachandran, Ellappan Babu, Sathish Sivaprakasam, Devaraja Rajasekaran et al. · 2020 · Asian Journal of Pharmaceutical Sciences
Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro
T C Hsieh, Yiwei Huang, JOSEPH M. WU · 2010 · Carcinogenesis
p53 activates G1 checkpoint following DNA damage by doxorubicin during transient mitotic arrest
Sun‐Yi Hyun, Young‐Joo Jang · 2014 · Oncotarget
Identification of novel radiation-induced p53-dependent transcripts extensively regulated during mouse brain development
Roel Quintens, Tine Verreet, Ann Janssen, Mieke Neefs, Liselotte Leysen, Arlette Michaux, Mieke Verslegers, Nada Samari, Giuseppe Pani, Joris Verheyde et al. · 2015 · Biology Open
Programmed cell death in stem cell-based therapy: Mechanisms and clinical applications
Ximin Hu, Qí Zhāng, Rui-Xin Zhou, Yanlin Wu, Zhixin Li, Dan-Yi Zhang, Yi-Chao Yang, Ronghua Yang, Yongjun Hu, Kun Xiong · 2021 · World Journal of Stem Cells
p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis
Sergio Rius‐Pérez · 2023 · Free Radical Biology and Medicine
DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction
Zhiwei Peter Wang, Hiroyuki Inuzuka, Jiateng Zhong, Hidefumi Fukushima, Lixin Wan, Pengda Liu, Wenyi Wei · 2012 · Oncotarget
RETRACTED: Targeted immunotherapy for HER2-low breast cancer with 17p loss
Yujing Li, Yifan Sun, Michael Kulke, Torsten Hechler, Kevin Van der Jeught, Tianhan Dong, Bin He, Kathy D. Miller, Milan Radovich, Bryan Paul Schneider et al. · 2021 · Science Translational Medicine · Retracted
As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect
Shuang Liu, Bin Yan, Weiwei Lai, Ling Chen, Desheng Xiao, Sichuan Xi, Yiqun Jiang, Xin Dong, Jing An, Xiang Chen et al. · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Wild-type p53 binds to MYC promoter G-quadruplex
Marek Petr, Robert Helma, Alena Polášková, Aneta Krejčí, Zuzana Dvořáková, Iva Kejnovská, Lucie Navrátilová, Matej Adámik, Michaela Vorlı́čková, Marie Brázdová · 2016 · Bioscience Reports
Correction: Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation
Jun Tang, Trisha Agrawal, Qian Cheng, Like Qu, Michael D. Brewer, Jiandong Chen, Xiaolu Yang · 2013 · PLoS ONE